Further to DrugAlert vol 805, HPS Pharmacies wish to advise that suppliers are continuing to experience a supply interruption for metronidazole tablets and suspension as follows:
|Product||ARTG||Estimated return date|
|Metrogyl® 200mg||17654||End-October 2022|
|Metrogyl® 400mg||17655||End-October 2022|
|Flagyl® 400mg||160174||Mid-November 2022|
|Flagyl® S Suspension||27501||Mid-late October 2022|
An internationally registered brand of metronidazole 400mg tablets has been approved for supply under Section 19A of the Therapeutic Goods Act 1989. Supplies of metronidazole for injection are currently unaffected by this shortage.
Retain this notice in a prominent position, including in other related business units until supplies return to normal. Report any problems identified with medicines, vaccines or medical devices to the TGA.
Should you require further information regarding this matter, please contact your pharmacist at HPS Pharmacies.
Subscribe Knowledge Centre Updates
Enter your details to receive Knowledge Centre updates